Search Results
Results found for "Norton Cheng"
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
is like adjusting the brightness on a microscope—set it right, and hidden details jump into focus, changing Can changing receptor density predict how your drug will behave across sensitive versus less sensitive That’s where Terry’s Corner changes the game.
- 📰 GPCR Weekly News, April 29 to May 5, 2024
announcements in today’s episode, so join us in this celebration and be the first to know about all the changes
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
“The first time I wore my lucky cactus shirt to a major meeting... and it led to a game-changing collaboration
- G protein coupling and activation of the metabotropic GABAB heterodimer
Cryo-electron microscopy studies revealed a drastic conformational change upon activation and a unique metadynamics computations to predict the mechanism by which the inactive GP induces conformational changes
- From Pipettes to Platforms: The Evolution of GPCR Research
What Changed After This : High-throughput capabilities meant researchers could map GPCR signaling more But the heart of the field hasn’t changed.
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
Moreover, we assess β-arrestin conformational changes that are induced specifically by proximal and distal Here, we show differences between conformational changes that are induced by P-R* or R* receptor states
- Why “Displacement” Misleads You: Allosteric Binding Demystified
Session, You’ll Gain: ✅ A clear explanation of why allosteric modulators don’t displace ligands—they change You’re no longer tracking the same protein species—and that changes everything.
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
The date never changed. But the scope moved. If nothing changes after it, it was just a lab update. shared, milestone-driven roadmap tied to strategic decisions, not just scientific deliverables, momentum changes
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
al. highlight the importance of GPCR dimers in drug discovery referring to important conformational changes But what are the conformation changes that drive GPCR dimerization? The interaction between two receptors in a dimer involves a conformational change in the transmembrane Interestingly, the amplitude of the conformational changes due to ligand binding is limited at these
- The Hidden Operating Cadence That’s Actually Driving Your Biotech
And until you see it, you can’t change it. What must change? What deserves escalation? ✅ A stable cadence doesn’t eliminate surprise.
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
This week brings sharp new insights into how minor changes in ligand structure can flip GPCR function
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
characterization of biased receptors may give insights into the relationship between the conformational change protein coupling bias of mutant AVPR2s may broaden our understanding of the relationship between the changed
- How System-Level GPCR Thinking Prevents Discovery Failures
Johannes Broichhagen Reliable imaging tools change how researchers see receptor behavior. specificity, relevance, and assay confidence Read the full HCS feature ➤ Why System-Level GPCR Thinking Changes
- SLAS2022 International Conference and Exhibition
We are closely monitoring any regulation changes from both Boston and Massachusetts with regard to in-person If there are any changes made that will impact our ability to hold the event in-person, we will notify
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
severe pain by activating the μ-opioid receptor (MOR), whereas naloxone, with only slight structural changes The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
Additionally, pull-down experiments demonstrated that YM promotes similar conformational changes in both Together, these results indicate that changes in membrane binding impact the ability of YM to inhibit
- Synaptic integration of subquantal neurotransmission by co-localized G protein coupled receptors in
We tested effects of changes in vesicle numbers undergoing fusion at single synapses, relative placement Experimental effects of Pr changes, consistent with GABAB receptor effects, were straightforwardly represented by changes in numbers of synapses. GABAB receptors alter Pr leaving synaptic properties unchanged, while 5-HT1B receptors fundamentally change
- How Early Strategic Decision Making Creates Alignment and Better Results
They only feel the consequences months later, when it is hard to change momentum. 👉 This article is Why Results Appear Too Late to Change the Outcome 👉 Most teams focus on results because results feel underlying strategy is sound. 👉 When early strategic decision-making creates alignment, something changes
- 📰 GPCR Weekly News, March 20 to 26, 2023
Structural and Molecular Insights into GPCR Function Physiological changes in bilayer thickness induced Ultrafast structural changes direct the first molecular events of vision. Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
But everything changed when his recurring pain — and the rigid protocols around opioid prescription —
- The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor
transmembrane helix 7 (TMH7) and the highly conserved NPXXY motif can be subject to different conformational changes
- ShouTi Pharma has a brand new website
experienced, innovative, global team on a bold mission to improve health by creating and developing life-changing
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
-ADR agonist terbutaline by flow cytometry. β2-ADR-expressing B cells increase during CIA without a change The change of β2-ADR expression and signaling during sustained inflammation might be an integral part
- Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
August 2022 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
the Danger Perhaps the most unsettling part of Catherine’s work is the disconnect between breathing changes That is why Catherine’s work matters: it shows in mechanistic detail how fentanyl and xylazine change
- Interacting binding insights and conformational consequences of the differential activity of...
simulations, we found that the presence of the CBD ligand in the GPR55 receptor elicit conformational changes The all-atom MD simulations reveal that CBD induces conformational changes linked with agonist-bound
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-Gi
- Molecular insights into regulation of constitutive activity by RNA editing 5HT2C serotonin receptor
September 2022 "RNA editing is a process by which post-transcriptional changes of mRNA nucleotides alter
- Decoding β-Arrestins: from Structure to function
Following extracellular stimulus detection, receptor activation initiates conformational changes, exposing an intracellular cavity (Kang, Y. et al. 2015, Chen, Q. et al. 2021), that allow interaction with trimeric F et al. 2021, Chen, H. et al. 2022). not all receptors recruit both isoforms equally and arrestins can undergo different conformational changes Changes in the availability of regulatory proteins like GRKs can impact GPCR phosphorylation and subsequent
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Terry Kenakin delivers a game-changing framework for teams grappling with the gap between in vitro potency His latest lecture is a guide to understanding why intracellular drug access changes everything—from












